Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Amendment 713 to House Bill 3
116th Congress(2019-2020)
An amendment numbered 3 printed in Part B of House Report 116-334 to to authorize a pilot program to develop, expand, and enhance the commercialization of biomedical products, and for other purposes.
Agreed To
Agreed to in House on Dec 12, 2019
Submitted
Dec 12, 2019
Latest Action
Dec 12, 2019
Origin Chamber
House
Type
Amendment
Amendment
A proposed change to a pending text (e.g., a bill, resolution, another amendment, or a treaty [or an associated resolution of ratification]).
Amendment Number
713
Congress
116
Sponsorship by Party
Democrat
Scott Peters
California
Actions (4)
12/12/2019
House amendment agreed to: On agreeing to the Peters amendment (A003) Agreed to by voice vote.
12/12/2019
On agreeing to the Peters amendment (A003) Agreed to by voice vote.
12/12/2019
Amendment (A003) offered by Mr. Peters. (consideration: CR H10204-10205; text: CR H10204)
12/12/2019
House amendment offered
Amended Bill
Dec 12, 2019
Passed House
107
Sponsorship
House Bill 3
Elijah E. Cummings Lower Drug Costs Now Act
Active
Amendments
Public Record
Record Updated
Feb 8, 2022 11:01:28 PM